ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PGEN vs HCM // FREE CASH FLOW YIELD

Precigen Inc. (NASDAQ) VS. HUTCHMED (China) Limited (NASDAQ) • 15-METRIC TALLY: PGEN 3 — HCM 5
▲ FREE CASH FLOW YIELD LEADER: HCM
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGEN VS. HCM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PGEN HCM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -2.50% -32.50 HCM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -3.78% -3.32% -0.46 HCM /fcf-yield <GO>
Operating Margin -60.00% -7.10% -52.90 HCM /operating-margins <GO>
Net Profit Margin -60.00% 68.00% -128.00 HCM /net-margins <GO>
Revenue Growth (YoY) 146.70% -13.00% +159.70 PGEN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.63 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 HCM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.3 41.1 +9.21 PGEN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 4.8x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.38B $2.37B $6.4M PGEN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PGEN REV HCM REV PGEN GROSS % HCM GROSS % PGEN FCF HCM FCF
FY 2025 $9.7M $548.5M — 38.7% -$89.8M -$78.8M
FY 2024 $3.9M $630.2M — 44.6% -$76.8M -$17.4M
FY 2023 $6.2M $838.0M — — -$66.9M $219.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGEN // BETA —
HCM // BETA —